公告 Notice of Effectiveness

发表于 2024-02-28 23:44   423次浏览

公告 Notice of Effectiveness

发表于 2024-02-28 19:29   435次浏览

公告 Notice of Effectiveness

发表于 2024-02-28 19:29   436次浏览

公告 Notice of Effectiveness

发表于 2024-02-28 19:25   421次浏览

公告 Current report, item 8.01

发表于 2024-02-27 05:57   431次浏览

公告 Post-Effective amendments for registration statement

发表于 2024-02-27 05:50   431次浏览

公告 Post-Effective amendments for registration statement

发表于 2024-02-27 05:50   430次浏览

公告 Post-Effective amendments for registration statement

发表于 2024-02-27 05:49   432次浏览

公告 Post-Effective amendments for registration statement

发表于 2024-02-27 05:49   431次浏览

公告 Securities to be offered to employees in employee benefit plans, post-effective

发表于 2024-02-27 05:44   433次浏览

公告 Securities to be offered to employees in employee benefit plans, post-effective

发表于 2024-02-27 05:44   427次浏览

公告 Securities to be offered to employees in employee benefit plans, post-effective

发表于 2024-02-27 05:43   424次浏览

公告 Notification filed by national security exchange to report the removal from lis

发表于 2024-02-15 22:01   450次浏览

公告 Initial statement of beneficial ownership of securities

发表于 2024-02-03 09:12   436次浏览

公告 Comera Life Sciences Holdings Inc|4：持股变动声明

发表于 2024-02-03 09:10   436次浏览

公告 Current report, items 2.04, 2.05, 5.02, and 8.01

发表于 2024-01-31 06:18   430次浏览

公告 Prospectus [Rule 424(b)(3)]

发表于 2024-01-31 06:15   425次浏览

公告 Prospectus [Rule 424(b)(3)]

发表于 2024-01-31 06:14   421次浏览

公告 Prospectus [Rule 424(b)(3)]

发表于 2024-01-31 06:13   439次浏览

公告 Statement of changes in beneficial ownership of securities

发表于 2024-01-12 08:19   446次浏览